Carta al Editor
Interacción valproato-meropenem como ejemplo de las deficiencias en la información sobre interacciones farmacológicas clínicamente relevantes
Valproate-meropenem interaction as an example of information shortcomings in relevant drug interactions
Carmen Ibáñez Ruiz, Carmen Esteban Calvo, Amparo Gil López-Oliva
, Antonio Cachá Acosta
Autor para correspondencia
Centro de Farmacovigilancia de la Comunidad de Madrid, Servicio de Control Farmacéutico y Productos Sanitarios, Consejería de Sanidad de la Comunidad de Madrid, Madrid, España
Leído
2205
Vecesse ha leído el artículo
195
Total PDF
2010
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2023 3 | 3 | 2 | 5 |
| 2017 10 | 7 | 0 | 7 |
| 2017 9 | 14 | 2 | 16 |
| 2017 8 | 15 | 2 | 17 |
| 2017 7 | 11 | 0 | 11 |
| 2017 6 | 15 | 1 | 16 |
| 2017 5 | 16 | 6 | 22 |
| 2017 4 | 14 | 10 | 24 |
| 2017 3 | 15 | 19 | 34 |
| 2017 2 | 26 | 1 | 27 |
| 2016 1 | 22 | 0 | 22 |
| 2016 12 | 30 | 5 | 35 |
| 2016 11 | 35 | 3 | 38 |
| 2016 10 | 42 | 4 | 46 |
| 2016 9 | 37 | 3 | 40 |
| 2016 8 | 31 | 5 | 36 |
| 2016 7 | 29 | 2 | 31 |
| 2016 6 | 42 | 9 | 51 |
| 2016 5 | 27 | 4 | 31 |
| 2016 4 | 20 | 3 | 23 |
| 2016 3 | 22 | 3 | 25 |
| 2016 2 | 23 | 3 | 26 |
| 2015 1 | 25 | 8 | 33 |
| 2015 12 | 44 | 3 | 47 |
| 2015 11 | 32 | 2 | 34 |
| 2015 10 | 42 | 7 | 49 |
| 2015 9 | 41 | 2 | 43 |
| 2015 8 | 31 | 5 | 36 |
| 2015 7 | 32 | 4 | 36 |
| 2015 6 | 23 | 1 | 24 |
| 2015 5 | 28 | 2 | 30 |
| 2015 4 | 36 | 12 | 48 |
| 2015 3 | 33 | 7 | 40 |
| 2015 2 | 29 | 8 | 37 |
| 2015 1 | 31 | 3 | 34 |
| 2014 12 | 46 | 6 | 52 |
| 2014 11 | 37 | 1 | 38 |
| 2014 10 | 43 | 2 | 45 |
| 2014 9 | 39 | 3 | 42 |
| 2014 8 | 46 | 2 | 48 |
| 2014 7 | 37 | 5 | 42 |
| 2014 6 | 31 | 3 | 34 |
| 2014 5 | 31 | 1 | 32 |
| 2014 4 | 32 | 4 | 36 |
| 2014 3 | 26 | 7 | 33 |
| 2014 2 | 24 | 1 | 25 |
| 2014 1 | 35 | 2 | 37 |
| 2013 12 | 29 | 2 | 31 |
| 2013 11 | 12 | 4 | 16 |
| 2013 6 | 5 | 1 | 6 |
| 2013 5 | 1 | 0 | 1 |
| 2010 11 | 613 | 0 | 613 |
Mostrar todo
